The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus

Biological disease-modifying antirheumatic drugs (bDMARDs) are highly effective agents for the treatment of inf lammatory arthritis; however, they also possess a potential risk for serious infection. Recently, with the rapid expansion of the bDMARDs market in Korea, reports of serious adverse events...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Korean J Intern Med
Hlavní autoři: Park, Eun-Jung, Kim, Hyungjin, Jung, Seung Min, Sung, Yoon-Kyoung, Baek, Han Joo, Lee, Jisoo
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Association of Internal Medicine 2020
Témata:
Guideline
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6960050/
https://ncbi.nlm.nih.gov/pubmed/31935319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2019.411
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky